Gene · 5889
Papers3,668
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,668
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer. | Front Genet | 2023 | 36896237 | PubTator, text mining | PubMed |
| Integration of bulk RNA sequencing and single-cell analysis reveals a global landscape of DNA damage response in the immune environment of Alzheimer's disease. | Front Immunol | 2023 | 36895559 | PubTator, text mining | PubMed |
| Prognostic value of genomic mutations in metastatic prostate cancer. | Heliyon | 2023 | 36895385 | PubTator, text mining | PubMed |
| Comprehensive laboratory diagnosis of Fanconi anaemia: comparison of cellular and molecular analysis. | J Med Genet | 2023 | 36894310 | PubTator, text mining | PubMed |
| Are population level familial risks and germline genetics meeting each other? | Hered Cancer Clin Pract | 2023 | 36882784 | PubTator, text mining | PubMed |
| Somatic mutation landscape in a cohort of meningiomas that have undergone grade progression. | BMC Cancer | 2023 | 36882706 | PubTator, text mining | PubMed |
| Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma. | Saudi J Biol Sci | 2023 | 36879671 | PubTator, text mining | PubMed |
| BRCA1 interactors, RAD50 and BRIP1, as prognostic markers for triple-negative breast cancer severity. | Front Genet | 2023 | 36873936 | PubTator, text mining | PubMed |
| Fighting resistance: post-PARP inhibitor treatment strategies in ovarian cancer. | Ther Adv Med Oncol | 2023 | 36872947 | PubTator, text mining | PubMed |
| Investigating the suitability of in vitro cell lines as models for the major subtypes of epithelial ovarian cancer. | Front Cell Dev Biol | 2023 | 36861035 | PubTator, text mining | PubMed |
| Pathogenic variants among females with breast cancer and a non-breast cancer reveal opportunities for cancer interception. | Breast Cancer Res Treat | 2023 | 36856935 | PubTator, text mining | PubMed |
| Precision Oncology in Pancreatic Cancer: Experiences and Challenges of the CCCMunichLMU Molecular Tumor Board. | Target Oncol | 2023 | 36853374 | PubTator, text mining | PubMed |
| Prevalence of Pathogenic Germline Mutations in 13 Hereditary Cancer-Related Genes in Breast Cancer Patients in Narathiwat Province, Thailand. | Asian Pac J Cancer Prev | 2023 | 36853301 | PubTator, text mining | PubMed |
| Evaluation of genetic alterations in hereditary cancer susceptibility genes in the Ashkenazi Jewish women community of Mexico. | Front Genet | 2023 | 36845387 | PubTator, text mining | PubMed |
| The use of Instagram by gynecologic oncology providers as a patient education tool for patients at high-risk of gynecologic cancer. | Gynecol Oncol Rep | 2023 | 36845024 | PubTator, text mining | PubMed |
| Hereditary Women's Cancer: Management and Risk-Reducing Surgery. | Medicina (Kaunas) | 2023 | 36837501 | PubTator, text mining | PubMed |
| Homologous Recombination Deficiency in Ovarian Cancer: from the Biological Rationale to Current Diagnostic Approaches. | J Pers Med | 2023 | 36836518 | PubTator, text mining | PubMed |
| Association of FANCM Mutations with Familial and Early-Onset Breast Cancer Risk in a South American Population. | Int J Mol Sci | 2023 | 36835452 | PubTator, text mining | PubMed |
| Unexpected Findings in Hereditary Breast and Ovarian Cancer Syndrome: Low-Level Constitutional Mosaicism in BRCA2. | Genes (Basel) | 2023 | 36833429 | PubTator, text mining | PubMed |
| Hereditary Cancer Syndrome in a Family with Double Mutation in BRIP1 and MUTYH Genes. | Genes (Basel) | 2023 | 36833355 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5889/papers?page=32